Vivek Mittal and others from Weill Cornell and Houston Methodist and Weill Cornell received a multi-million dollar grant to support their tumor microenviroment and crosstalk studies. Read more
Claudia Fischbach-Teschl, Ph.D., pens a guest post about the importance of targeting the tumor microenvironment in cancer research and therapy. Read more
A team led by Ari Melnick, M.D., has found that a genetic mutation implicated in a common and incurable form of non-Hodgkin lymphoma drives disease development by disrupting the mechanism that manages normal immune cell growth. Read more
Ashish Saxena, M.D., Ph.D., comments on a study that found nivolumab offers better outcomes than docetaxel for patients with advanced squamous-cell non-small cell lung cancer. Read more
Watchful waiting or active treatment? Jim Hu, M.D., has studied surveillance strategies among patients diagnosed with localized prostate cancer. Read more
Studies into the role of estrogen receptors in prostate cancer by Dimple Chakravarty and colleagues are highlighted in an article about noncoding RNAs. Read more
A study by Claudia Fischbach, Andrew Dannenberg and others has found that obesity changes the consistency of breast tissue in ways that are similar to tumors, thereby promoting disease. Read more